Ovarian Cancer: Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer
in Low Risk Women
Can the blood test, CA-125 be helpful in the early detection of ovarian cancer in
women who are at low risk?
Basic Study Information
Purpose:Location: Cancer Center
You will have blood drawn for the CA-125 testing and other tumor markers, depending
on your CA-125 level, you will return and have blood drawn in 1 year or in 3 months
or in 6 weeks plus a transvaginal ultrasound.
Study Web URL: https://clinicaltrials.gov/ct2/show/NCT00539162?term=ID01-022&rank=1
Study Reference #: UGYO17017
Lead Researcher (Principal Investigator)
Lead Researcher: Richard Moore
Study Contact InformationStudy Coordinator: Laura Mitchell
Phone: (585) 275-7763
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search